Sabrina Browning, MD
Research & Publications
Biography
News
Research Summary
Dr. Browning's research interests include the study of new treatments for multiple myeloma and AL amyloidosis as well as the effect of therapy on patients' quality of life. She is also interested in exploring potential inherited risk factors for the development of these diseases. She will be pursuing studies to better understand how to manage classic hematology problems, including clotting and bleeding, which may occur in patients with multiple myeloma or AL amyloidosis. She has also worked with the Yale Convalescent Plasma Therapy in COVID-19 group to investigate the role of transfusing plasma collected from donors who have recovered from COVID-19 to those currently sick with the disease in an attempt to improve their breathing status and other outcomes.
Coauthors
Research Interests
Quality of Life; Therapeutics; Whole Exome Sequencing
Selected Publications
- Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state.Browning S, Bahar B, Lee AI, Gorshein E. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. Hematology (Amsterdam, Netherlands) 2020, 25: 473-477. PMID: 33269995, DOI: 10.1080/16078454.2020.1848973.
- Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation.Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood 2017, 130: 1383-1386. PMID: 28698204, DOI: 10.1182/blood-2017-06-788729.
- Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant.Prokaeva T, Akar H, Spencer B, Havasi A, Cui H, O'Hara CJ, Gursky O, Leszyk J, Steffen M, Browning S, Rosenberg A, Connors LH. Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant. Kidney International Reports 2017, 2: 1223-1232. PMID: 29270531, PMCID: PMC5733886, DOI: 10.1016/j.ekir.2017.07.009.
- Current management of sickle cell disease in pregnancy.Andemariam B, Browning SL. Current management of sickle cell disease in pregnancy. Clinics In Laboratory Medicine 2013, 33: 293-310. PMID: 23702119, DOI: 10.1016/j.cll.2013.03.023.
- Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19.Briggs N, Gormally MV, Li F, Browning SL, Treggiari MM, Morrison A, Laurent-Rolle M, Deng Y, Hendrickson JE, Tormey CA, Desruisseaux MS. Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19. PloS One 2021, 16: e0254453. PMID: 34320004, PMCID: PMC8318280, DOI: 10.1371/journal.pone.0254453.
- Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.Martin RL, Grant MJ, Kimani S, Midha S, May J, Patell R, Collier E, Furfaro D, Bodine C, Reap L, Shah N, DeLaune J, Brusca S, Olazagasti C, Goyal S, Rubinstein S, Hakim N, Qin S, Browning SL, Sena L, Gilbert J, Davidson M, Lovly CM, Seetharamu N, Rangachari D, Murphy M, Chatwal M, Paschal R, Henry E, Collichio F, Green JR. Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform. JCO Oncology Practice 2022, 18: e36-e46. PMID: 34242082, PMCID: PMC8758064, DOI: 10.1200/OP.20.00960.